Table 2

Primary and secondary objectives

Primary objectives

  • To describe the characteristics of paediatric patients with moderate-to-severe AD whose disease is not adequately controlled with topical therapies or when those therapies are not medically advisable.

  • To evaluate the time course of AD and selected atopic comorbidities.

Secondary objectives

  • To characterise disease burden and unmet need.

  • To describe real-world treatment patterns (eg, dosing regimens, treatment duration and reasons for discontinuation and/or switching).

  • To document the real-world effectiveness and safety of treatments.

  • AD, atopic dermatitis;